Literature DB >> 25012997

Metabolic health reduces risk of obesity-related cancer in framingham study adults.

Lynn L Moore1, Susan Chadid2, Martha R Singer2, Bernard E Kreger3, Gerald V Denis4.   

Abstract

BACKGROUND: It is unknown whether the risk for obesity-related cancers differs between metabolically unhealthy and healthy overweight/obese adults.
METHODS: Data on body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and random blood glucose in Framingham Heart Study adults (n = 3,763) ages 55 to 69 years were used to estimate risks of obesity-related cancers (n = 385), including postmenopausal breast, female reproductive, colon, liver, gallbladder, pancreas, and kidney cancers, as well as esophageal adenocarcinomas. Multivariable-adjusted Cox proportional hazards models were used to estimate risk for obesity-related cancers associated with body fat and metabolic health (as defined by glucose levels) among subjects in three risk groups (vs. referent group with normal weight/normal glucose): normal weight/elevated glucose, overweight/normal glucose, and overweight/elevated glucose.
RESULTS: Overweight adults [BMI ≥ 25 or WHtR ≥ 0.51 (men) and ≥0.57 (women)] with elevated glucose (≥125 mg/dL) had a statistically significant 2-fold increased risk of developing obesity-related cancer, whereas overweight adults with normal glucose had a 50% increased risk. Normal-weight adults with elevated glucose had no excess cancer risk. The effects of BMI and WHtR were independent of one another. Finally, overweight women with elevated blood glucose had a 2.6-fold increased risk [95% confidence interval (CI), 1.4-4.9] of female reproductive (cervical, endometrial, uterine cancers) and postmenopausal breast cancers, whereas overweight women with normal glucose levels had only a 70% increased risk (95% CI, 1.1-2.5).
CONCLUSION: These results suggest that cancer risk may be lower among metabolically healthy overweight/obese older adults than among overweight/obese adults with metabolic dysfunction. IMPACT: Metabolic dysfunction and obesity act synergistically to increase cancer risk. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25012997      PMCID: PMC4184957          DOI: 10.1158/1055-9965.EPI-14-0240

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

Review 1.  ABC of obesity. Obesity and cancer.

Authors:  Donald C McMillan; Naveed Sattar; Colin S McArdle
Journal:  BMJ       Date:  2006-11-25

2.  Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.

Authors:  Caroline S Fox; Sean Coady; Paul D Sorlie; Ralph B D'Agostino; Michael J Pencina; Ramachandran S Vasan; James B Meigs; Daniel Levy; Peter J Savage
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

3.  The cancer experience in the Framingham Heart Study cohort.

Authors:  B E Kreger; G L Splansky; A Schatzkin
Journal:  Cancer       Date:  1991-01-01       Impact factor: 6.860

Review 4.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

5.  Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.

Authors:  C-S Kim; H-S Park; T Kawada; J-H Kim; D Lim; N E Hubbard; B-S Kwon; K L Erickson; R Yu
Journal:  Int J Obes (Lond)       Date:  2006-03-14       Impact factor: 5.095

6.  Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Authors:  David C Ziemer; Paul Kolm; Jovonne K Foster; William S Weintraub; Viola Vaccarino; Mary K Rhee; Rincy M Varughese; Circe W Tsui; David D Koch; Jennifer G Twombly; K M Venkat Narayan; Lawrence S Phillips
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

Review 7.  Leptin: a pivotal regulator of human energy homeostasis.

Authors:  I Sadaf Farooqi; Stephen O'Rahilly
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

8.  Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women.

Authors:  Maria Adelaide Marini; Elena Succurro; Simona Frontoni; Marta Letizia Hribal; Francesco Andreozzi; Renato Lauro; Francesco Perticone; Giorgio Sesti
Journal:  Diabetes Care       Date:  2007-05-16       Impact factor: 19.112

Review 9.  Adipocytokines and cancer.

Authors:  D Housa; J Housová; Z Vernerová; M Haluzík
Journal:  Physiol Res       Date:  2005-10-17       Impact factor: 1.881

10.  Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.

Authors:  D Sharma; N K Saxena; P M Vertino; F A Anania
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

View more
  43 in total

1.  The association between metabolic health, obesity phenotype and the risk of breast cancer.

Authors:  Yong-Moon Mark Park; Alexandra J White; Hazel B Nichols; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler
Journal:  Int J Cancer       Date:  2017-03-28       Impact factor: 7.396

2.  "Obesity-Associated" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk.

Authors:  Gerald V Denis; Julie R Palmer
Journal:  Cancer Prev Res (Phila)       Date:  2017-04-13

Review 3.  BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Authors:  Dequina A Nicholas; Guillaume Andrieu; Katherine J Strissel; Barbara S Nikolajczyk; Gerald V Denis
Journal:  Cell Mol Life Sci       Date:  2016-08-04       Impact factor: 9.261

4.  Mortality disparities: A comparison with the Haudenosaunee in New York State.

Authors:  Rodney C Haring; Melissa A Jim; Deborah Erwin; Judith Kaur; Whitney Ann E Henry; Marissa L Haring; Dean S Seneca
Journal:  Cancer Health Disparities       Date:  2018-06-29

5.  Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.

Authors:  Elizabeth M Cespedes Feliciano; Candyce H Kroenke; Jeffrey A Meyerhardt; Carla M Prado; Patrick T Bradshaw; Andrew J Dannenberg; Marilyn L Kwan; Jingjie Xiao; Charles Quesenberry; Erin K Weltzien; Adrienne L Castillo; Bette J Caan
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

6.  The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.

Authors:  Alina M Allen; Stephen B Hicks; Kristin C Mara; Joseph J Larson; Terry M Therneau
Journal:  J Hepatol       Date:  2019-08-27       Impact factor: 25.083

Review 7.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

Review 8.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 9.  Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation.

Authors:  Kristen M Humphrey; Sumali Pandey; Jeffery Martin; Tamara Hagoel; Anne Grand'Maison; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

10.  Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.

Authors:  Jacqueline M Hirth; Tabassum Haque Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2015-11-18       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.